Janus Henderson Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Hold |
160,443
| – | – | ﹤0.01% | 1333 |
|
|
2025
Q1 | $1.66M | Sell |
160,443
-14,700
| -8% | -$153K | ﹤0.01% | 1371 |
|
|
2024
Q4 | $2.07M | Hold |
175,143
| – | – | ﹤0.01% | 1291 |
|
|
2024
Q3 | $2.02M | Hold |
175,143
| – | – | ﹤0.01% | 1309 |
|
|
2024
Q2 | $1.85M | Buy |
175,143
+48,200
| +38% | +$509K | ﹤0.01% | 1294 |
|
|
2024
Q1 | $1.34M | Sell |
126,943
-24
| -0% | -$253 | ﹤0.01% | 1488 |
|
|
2023
Q4 | $1.43M | Sell |
126,967
-3,851,530
| -97% | -$43.3M | ﹤0.01% | 1434 |
|
|
2023
Q3 | $46.5M | Sell |
3,978,497
-470,924
| -11% | -$5.5M | 0.03% | 373 |
|
|
2023
Q2 | $44.9M | Sell |
4,449,421
-312,017
| -7% | -$3.15M | 0.03% | 408 |
|
|
2023
Q1 | $35.1M | Buy |
4,761,438
+4,714,774
| +10,104% | +$34.8M | 0.02% | 458 |
|
|
2022
Q4 | $373K | Sell |
46,664
-46,664
| -50% | -$373K | ﹤0.01% | 1865 |
|
|
2022
Q3 | $300K | Buy |
93,328
+25,461
| +38% | +$81.8K | ﹤0.01% | 2213 |
|
|
2022
Q2 | $277K | Buy |
+67,867
| New | +$277K | ﹤0.01% | 2124 |
|